Zimmer Biomet
1,032 hedge funds and large institutions have $22.5B invested in Zimmer Biomet in 2023 Q4 according to their latest regulatory filings, with 127 funds opening new positions, 280 increasing their positions, 427 reducing their positions, and 96 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 9 → 12 (+3)
32% more first-time investments, than exits
New positions opened: 127 | Existing positions closed: 96
9% more capital invested
Capital invested by funds: $20.6B → $22.5B (+$1.92B)
2% more funds holding
Funds holding: 1,015 → 1,032 (+17)
0.82% more ownership
Funds ownership: 87.6% → 88.41% (+0.82%)
14% less call options, than puts
Call options by funds: $102M | Put options by funds: $118M
34% less repeat investments, than reductions
Existing positions increased: 280 | Existing positions reduced: 427
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
+$742M |
| 2 |
Neuberger Berman Group
New York
|
+$213M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$163M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$119M |
| 5 |
SCM
Shapiro Capital Management
Atlanta,
Georgia
|
+$111M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$327M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$211M |
| 3 |
Holocene Advisors
New York
|
-$129M |
| 4 |
NI
Nuance Investments
Kansas City,
Missouri
|
-$109M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$102M |
ZBH Hedge Fund Activity: Q4 2023 in Review
1,032 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q4 2023, worth a combined $22.5B — up 9.3% from $20.6B a quarter earlier.
Buyers outnumbered sellers: 127 funds opened new ZBH positions and 96 closed out — a net gain of 31 holders — while 280 added to existing stakes and 427 trimmed.
The largest buyer was Dodge & Cox, adding an estimated $742M. The largest seller was BlackRock, cutting an estimated $327M.
- 1,032 institutional investors held Zimmer Biomet (ZBH) as of Q4 2023, up from 1,015 in Q3 2023.
- Funds reported $22.5B of Zimmer Biomet stock for Q4 2023, up 9.3% quarter-over-quarter.
- 127 funds opened new Zimmer Biomet positions in Q4 2023 and 96 closed out, a net change of +31 holders.
- The largest Zimmer Biomet buyer in Q4 2023 was Dodge & Cox, an estimated $742M added.
- The largest Zimmer Biomet seller in Q4 2023 was BlackRock, an estimated $327M sold.
Based on aggregated 13F filings for Q4 2023.